Skip to content

Comparison of AmblyzTM Glasses and Patching for Amblyopia

Comparison of AmblyzTM Glasses and Patching for Amblyopia

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01973348
Enrollment
45
Registered
2013-10-31
Start date
2013-11-30
Completion date
2016-05-31
Last updated
2017-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia

Keywords

amblyopia

Brief summary

Electronic eyeglasses, Amblyz™glasses, are a new medical device designed to treat amblyopia, which intermittently become opaque and provide effective occlusion for 50% of the time they are worn. A non-randomized study reported that Amblyz glasses yield an improvement in the amblyopic eye and offer an alternative effective treatment. We are unaware of any randomized clinical trial reports of response to AmblyzTM glasses treatment of amblyopia. Our hypothesis: Amblyz™glasses can improve visual acuity of the amblyopic eye as effective as traditional patching treatment. The primary objective is to determine if AmblyzTM equally treats moderate amblyopia as the standard 2-hour patching treatment and AmblyzTM equally treats severe amblyopia as the standard 6-hour patching treatment. This study is designed to evaluate the effectiveness of a novel amblyopia treatment, AmblyzTM glasses, in treating amblyopia. Moderate amblyopia: Children ages 3 to \<8 years with visual acuity of 20/40 to 20/80 in the amblyopic eye will be enrolled and randomized into two groups: 4-hour AmblyzTM glasses treatment group and standard 2-hour patching control group. Severe amblyopia: Children ages 3 to \<8 years with visual acuity of 20/100 to 20/400 in the amblyopic eye will be enrolled and randomized into two groups: 12-hour AmblyzTM glasses treatment group and standard 6-hour patching control group.

Interventions

DEVICE4-hour AmblyZ glasses

4-hour AmblyZ glasses for moderate amblyopia

DEVICE12-hour AmblyZ glasses

12-hour AmblyZ glasses for severe amblyopia

DEVICE2-hour patching

2-hour patching for moderate amblyopia

DEVICE6-hour patching

6-hour patching for severe amblyopia

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* Both genders and all races are eligible to this study. * Age 3 to 8 years * Amblyopia associated with strabismus, anisometropia, or both * Visual acuity in the amblyopic eye between 20/40 and 20/80 inclusive * Visual acuity in the sound eye 20/40 or better and inter-eye acuity difference \>3 logarithm of the minimum angle of resolution (logMAR) lines * Wearing of optimal spectacle correction for a minimum of 4 weeks at the time of enrollment.

Exclusion criteria

• No amblyopia treatment before enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity Change During 12 Weeks12 weeksVisual acuity change during 12 weeks: the difference of visual acuity at baseline and 12 weeks.

Other

MeasureTime frameDescription
Reverse Amblyopia3 Monthsit is defined that the strong eye of the patient decreases two logMAR lines over 3 months.
Significant Ocular Deviation Increase From the Baseline3 MonthsThe significant ocular deviation is defined as equal or over 10 degrees of deviation more than that of the baseline.

Countries

United States

Participant flow

Recruitment details

49 patients were consented; 45 entered the trial, with 27 assigned to the IO therapy group and 18 to the patching group.

Pre-assignment details

49 patients were consented; 4 patients were not qualified. 45 entered the trial, with 27 assigned to the IO therapy group and 18 to the patching group

Participants by arm

ArmCount
4-hour AmblyZ Glasses
4-hour AmblyZ glasses for moderate amblyopia 4-hour AmblyZ glasses: 4-hour AmblyZ glasses for moderate amblyopia
19
2-hour Eye Patching
2-hour eye patching for moderate amblyopia 2-hour patching: 2-hour patching for moderate amblyopia
15
12-hour AmblyZ Glasses
12-hour AmblyZ glasses for severe amblyopia 12-hour AmblyZ glasses: 12-hour AmblyZ glasses for severe amblyopia
0
6-hour Eye Patching
6-hour eye patching for severe amblyopia 6-hour patching: 6-hour patching for severe amblyopia
0
Total34

Baseline characteristics

Characteristic2-hour Eye Patching4-hour AmblyZ GlassesTotal
Age, Categorical
<=18 years
15 Participants19 Participants34 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous5.9 year old
STANDARD_DEVIATION 0.9
5.7 year old
STANDARD_DEVIATION 1.5
5.8 year old
STANDARD_DEVIATION 1.2
Region of Enrollment
United States
15 participants19 participants34 participants
Sex: Female, Male
Female
7 Participants5 Participants12 Participants
Sex: Female, Male
Male
8 Participants14 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 150 / 00 / 0
other
Total, other adverse events
0 / 190 / 150 / 00 / 0
serious
Total, serious adverse events
0 / 190 / 150 / 00 / 0

Outcome results

Primary

Visual Acuity Change During 12 Weeks

Visual acuity change during 12 weeks: the difference of visual acuity at baseline and 12 weeks.

Time frame: 12 weeks

Population: Visual acuity change over 12 weeks

ArmMeasureValue (MEAN)Dispersion
4-hour AmblyZ GlassesVisual Acuity Change During 12 Weeks.15 logMARStandard Deviation 0.12
2-hour Eye PatchingVisual Acuity Change During 12 Weeks.15 logMARStandard Deviation 0.11
p-value: 0.88t-test, 1 sided
Other Pre-specified

Reverse Amblyopia

it is defined that the strong eye of the patient decreases two logMAR lines over 3 months.

Time frame: 3 Months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
4-hour AmblyZ GlassesReverse Amblyopia0 Participants
2-hour Eye PatchingReverse Amblyopia0 Participants
12-hour AmblyZ GlassesReverse Amblyopia0 Participants
6-hour Eye PatchingReverse Amblyopia0 Participants
Other Pre-specified

Significant Ocular Deviation Increase From the Baseline

The significant ocular deviation is defined as equal or over 10 degrees of deviation more than that of the baseline.

Time frame: 3 Months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
4-hour AmblyZ GlassesSignificant Ocular Deviation Increase From the Baseline0 Participants
2-hour Eye PatchingSignificant Ocular Deviation Increase From the Baseline0 Participants
12-hour AmblyZ GlassesSignificant Ocular Deviation Increase From the Baseline0 Participants
6-hour Eye PatchingSignificant Ocular Deviation Increase From the Baseline0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026